骆海明 - 华中科技大学 - 武汉光电国家研究中心

个人简介

2013获得华中科技大学生物医学工程专业博士学位。2013-2015美国威斯康星大学麦迪逊分校博士后（合作导师：获杰出成就奖蔡伟波教授）；2015-2018哈佛医学院麻省总医院研究员（合作导师：Annie Chan教授）；2016-2018麻省理工大学麦戈文脑科学研究院研究会员（合作导师：美国科学院院士冯国平教授）。2018入职华中科技大学武汉光电国家研究中心生物医学光子学研究中心。

研究领域

神经肿瘤光学成像：阿尔兹海默症、脑胶质瘤研究方向

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1) Luo H, Hernandez R, Hong H, Graves SA, Yang Y, England CG, Theuer CP, Nickles RJ, Cai W. Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry. Proc Natl Acad Sci U S A. 2015, 112(41):12806-11 2) Luo H, England CG, Shi S, Graves SA, Hernandez R, Liu B, Theuer CP, Wong HC, Nickles RJ, Cai W. Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer. Clin Cancer Res. 2016, 22(15):3821-30. 3) Luo H, Lu L, Yang F, Wang L, Yang X, Luo Q, Zhang Z. Nasopharyngeal cancer-specific therapy based on fusion peptide-functionalized lipid nanoparticles. ACS Nano. 2014, 8(5):4334-47. 4) Luo H, England CG, Goel S, Graves SA, Ai F, Liu B, Theuer CP, Wong HC, Nickles RJ, Cai W. ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment. Mol Pharm. 2017, 14(5):1646-1655 5) Luo H, England CG, Graves SA, Sun H, Liu G, Nickles RJ, Cai W. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab. J Nucl Med. 2016, 57(2):285-90. 6) Luo H, Hong H, Slater MR, Graves SA, Shi S, Yang Y, Nickles RJ, Fan F, Cai W. PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor. J Nucl Med. 2015, 56(6):927-32 7) Luo H, Hong H, Yang SP, Cai W. Design and applications of bispecific heterodimers: molecular imaging and beyond. Mol Pharm. 2014, 11(6):1750-61 8) Luo H, Shi J, Jin H, Fan D, Lu L, Wang F, Zhang Z. An (125)I-labeled octavalent peptide fluorescent nanoprobe for tumor-homing imaging in vivo. Biomaterials. 2012, 33(19):4843-50 9) Luo H, Yang J, Jin H, Huang C, Fu J, Yang F, Gong H, Zeng S, Luo Q, Zhang Z. Tetrameric far-red fluorescent protein as a scaffold to assemble an octavalent peptide nanoprobe for enhanced tumor targeting and intracellular uptake in vivo. FASEB J. 2011, 25(6):1865-73